Cargando…

High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis

INTRODUCTION: Docosahexaenoic acid (DHA) supplementation in the neonatal period has been proposed to prevent bronchopulmonary dysplasia (BPD) in very preterm infants. We aim to determine the effects of an enteral supplementation with high doses of DHA on the risk for BPD at 36 weeks’ postmenstrual a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marc, Isabelle, Boutin, Amélie, Pronovost, Etienne, Guillot, Mireille, Bergeron, Frédéric, Moore, Lynne, Makrides, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Paediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577938/ https://www.ncbi.nlm.nih.gov/pubmed/36253040 http://dx.doi.org/10.1136/bmjopen-2022-064515

Ejemplares similares

Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis
por: Marc, Isabelle, et al.
Publicado: (2023)

Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis
por: Marc, Isabelle, et al.
Publicado: (2023)

Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS)
por: Guillot, Mireille, et al.
Publicado: (2022)

Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: an observational study
por: Lio, Alessandra, et al.
Publicado: (2017)

Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2018)

Delivery room interventions to prevent bronchopulmonary dysplasia in preterm infants: a protocol for a systematic review and network meta-analysis
por: Mitra, Souvik, et al.
Publicado: (2019)

Protocol for assessing whether cognition of preterm infants <29 weeks’ gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021)

Association between bronchopulmonary dysplasia and cerebral palsy in children: a meta-analysis
por: Gou, Xiaoyun, et al.
Publicado: (2018)

Steroid use for established bronchopulmonary dysplasia: study protocol for a systematic review and meta-analysis
por: Strashun, Sabina, et al.
Publicado: (2022)

Severe bronchopulmonary dysplasia in extremely premature infants: a scoping review protocol for identifying risk factors
por: Kato, Shin, et al.
Publicado: (2022)

Neurodevelopmental outcomes at 7 years’ corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial
por: Collins, Carmel T, et al.
Publicado: (2015)

Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study
por: Baker, Elizabeth Kate, et al.
Publicado: (2019)

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
por: Muehlbacher, Tobias, et al.
Publicado: (2021)

Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012–2019: a retrospective population cohort study
por: Yao, Sijia, et al.
Publicado: (2022)

Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm
por: Sullivan, Thomas R., et al.
Publicado: (2023)

The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks’ gestation
por: Collins, Carmel T., et al.
Publicado: (2016)

Docosahexaenoic acid-rich algae oil supplementation in mothers of preterm infants is associated with a modification in breast milk oxylipins profile
por: Fougère, Hélène, et al.
Publicado: (2023)

Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
por: Balink, Stephanie, et al.
Publicado: (2022)

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach
por: Jensen, Erik A., et al.
Publicado: (2019)

The Most Valuable Predictive Factors for Bronchopulmonary Dysplasia in Very Preterm Infants
por: Chen, Wenwen, et al.
Publicado: (2023)

Study protocol: treatment with caffeine of the very preterm infant in the delivery room: a feasibility study
por: Dani, Carlo, et al.
Publicado: (2020)

Early prediction of typical outcome and mild developmental delay for prioritisation of service delivery for very preterm and very low birthweight infants: a study protocol
por: Caesar, Rebecca, et al.
Publicado: (2016)

Approaches to supporting lactation and breastfeeding for very preterm infants in the NICU: a qualitative study in three European regions
por: Bonet, Mercedes, et al.
Publicado: (2015)

SuPreme Study: a protocol to study the neuroprotective potential of sulfate among very/extremely preterm infants
por: Hurrion, Elizabeth M, et al.
Publicado: (2023)

Early urine output monitoring in very preterm infants to predict in-hospital neonatal outcomes: a bicentric retrospective cohort study
por: De Mul, Aurélie, et al.
Publicado: (2023)

The effects of designation and volume of neonatal care on mortality and morbidity outcomes of very preterm infants in England: retrospective population-based cohort study
por: Watson, S I, et al.
Publicado: (2014)

Age of onset of necrotising enterocolitis (NEC) and focal intestinal perforation (FIP) in very preterm and low birthweight infants: a systematic review
por: Dermyshi, Elda, et al.
Publicado: (2023)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Long-term neuroprotective effect of erythropoietin on executive functions in very preterm children (EpoKids): protocol of a prospective follow-up study
por: Wehrle, Flavia Maria, et al.
Publicado: (2018)

Machine learning for prediction of bronchopulmonary dysplasia-free survival among very preterm infants
por: Leigh, Rebekah M., et al.
Publicado: (2022)

The value of hematocrit for predicting bronchopulmonary dysplasia in very low birth weight preterm infants
por: Wang, Xuesong, et al.
Publicado: (2023)

Early antibiotic use and incidence of necrotising enterocolitis in very preterm infants: a protocol for a UK based observational study using routinely recorded data
por: Shen, Rene, et al.
Publicado: (2022)

Developmental dysplasia of the hip: update of management
por: Vaquero-Picado, Alfonso, et al.
Publicado: (2019)

Protocol for assessing if behavioural functioning of infants born <29 weeks’ gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial
por: Gould, Jacqueline F, et al.
Publicado: (2021)

The apparent breastfeeding paradox in very preterm infants: relationship between breast feeding, early weight gain and neurodevelopment based on results from two cohorts, EPIPAGE and LIFT
por: Rozé, Jean-Christophe, et al.
Publicado: (2012)

Early markers of neurodevelopmental disorders based on general movements for very preterm infants: study protocol for a multicentre prospective cohort study in a clinical setting in China
por: Wang, Jun, et al.
Publicado: (2023)

Retinopathy of Prematurity and Bronchopulmonary Dysplasia are Independent Antecedents of Cortical Maturational Abnormalities in Very Preterm Infants
por: Kline, Julia E., et al.
Publicado: (2019)

Association of the dysfunctional placentation endotype of prematurity with bronchopulmonary dysplasia: a systematic review, meta-analysis and meta-regression
por: Pierro, Maria, et al.
Publicado: (2022)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h203c4ot1hfrvsdosgvanapnrc